BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 3109385)

  • 1. Phosphonic analogues of tyrosine and 3,4-dihydroxyphenylalanine (dopa) influence mushroom tyrosinase activity.
    Lejczak B; Kafarski P; Makowiecka E
    Biochem J; 1987 Feb; 242(1):81-8. PubMed ID: 3109385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of mushroom tyrosinase by 3-amino-L-tyrosine: molecular probing of the active site of the enzyme.
    Maddaluno JF; Faull KF
    Experientia; 1988 Oct; 44(10):885-7. PubMed ID: 3141207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of methimazole on the activity of mushroom tyrosinase.
    Andrawis A; Kahn V
    Biochem J; 1986 Apr; 235(1):91-6. PubMed ID: 3091005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox reaction between amino-(3,4-dihydroxyphenyl)methyl phosphonic acid and dopaquinone is responsible for the apparent inhibitory effect on tyrosinase.
    Gasowska B; Wojtasek H; Hurek J; Drag M; Nowak K; Kafarski P
    Eur J Biochem; 2002 Aug; 269(16):4098-104. PubMed ID: 12180986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of tyrosinase activity by 4-tert-butylcatechol and other depigmenting agents.
    Usami Y; Landau AB; Fukuyama K; Gellin GA
    J Toxicol Environ Health; 1980 May; 6(3):559-67. PubMed ID: 6775084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-OH-dopa, product of and substrate for tyrosinase.
    Agrup G; Rorsman H; Rosengren E
    Acta Derm Venereol; 1982; 62(5):371-76. PubMed ID: 6183884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxygenation of fluorinated tyrosines by mushroom tyrosinase releases fluoride ion.
    Phillips RS; Fletcher JG; Von Tersch RL; Kirk KL
    Arch Biochem Biophys; 1990 Jan; 276(1):65-9. PubMed ID: 2105082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of substituted DL-3(5-benzazolyl)alanines as dopa and alpha-methyldopa analogs and their effects on dopamine beta-hydroxylase, tyrosinase and diphenoloxidase.
    Loriga M; Paglietti G; Sparatore F; Pinna G; Sisini A
    Farmaco; 1992 Apr; 47(4):439-48. PubMed ID: 1388592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of tyrosinase by indole compounds and reaction products. Protection by albumin.
    Miranda M; Urbani G; Di Vito L; Botti D
    Biochim Biophys Acta; 1979 Jul; 585(3):398-404. PubMed ID: 114228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of hydroxylation of tyrosine and tyrosine-containing peptides by mushroom tyrosinase.
    Marumo K; Waite JH
    Biochim Biophys Acta; 1986 Jul; 872(1-2):98-103. PubMed ID: 3089286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphonic and phosphinic acid analogues of tyrosine and 3,4-dihydroxyphenylalanine (dopa) as potential antimelanotic agents.
    Lejczak B; Duś D; Kafarski P
    Anticancer Drug Des; 1990 Nov; 5(4):351-8. PubMed ID: 2127180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthesis of a DOPA analogue, 1-amino-2-(3, 4-dihydroxyphenyl)-ethylphosphonic acid and distribution studies in mice bearing the Harding-Passey melanoma.
    Stringer MJ; Stock JA; Cobb LM
    Chem Biol Interact; 1974 Dec; 9(6):411-21. PubMed ID: 4215573
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of catalase on the inactivation of tyrosinase by ascorbic acid and by cysteine or glutathione.
    Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(3):209-14. PubMed ID: 6192633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subunit differences among the multiple forms of mushroom tyrosinase [proceedings].
    Robb DA
    Biochem Soc Trans; 1979 Feb; 7(1):131-2. PubMed ID: 108144
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of polyphenol oxidase by copper-metallothionein from Aspergillus niger.
    Goetghebeur M; Kermasha S
    Phytochemistry; 1996 Jul; 42(4):935-40. PubMed ID: 8688193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of human tyrosinase by cysteine. Protection by dopa and tyrosine.
    Jergil B; Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1984; 64(2):155-7. PubMed ID: 6203305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposome-entrapped tyrosinase: a tool to investigate the regulation of the Raper-Mason pathway.
    Miranda M; Amicarelli F; Poma A; Ragnelli AM; Arcadi A
    Biochim Biophys Acta; 1988 Sep; 966(3):276-86. PubMed ID: 3137975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research on aminoalkylphosphonic acids. I. Action of tyrosinase on the phosphonic analogue of tyrosine].
    Cassaigne A; Lacoste AM; Neuzil E
    Bull Soc Chim Biol (Paris); 1967; 49(12):1813-25. PubMed ID: 4966404
    [No Abstract]   [Full Text] [Related]  

  • 19. Production of 6-hydroxydopa by human tyrosinase.
    Hansson C; Rorsman H; Rosengren E; Wittbjer A
    Acta Derm Venereol; 1985; 65(2):154-7. PubMed ID: 2408419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid quantitative analysis of tyrosine and its oxidation products by tyrosinase.
    Menezo Y; Voulot C; Ortonne JP; Khatchadourian C
    Arch Dermatol Res; 1978 Dec; 263(3):267-72. PubMed ID: 119492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.